Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The genomic landscape of nasopharyngeal carcinoma.

Lin DC, Meng X, Hazawa M, Nagata Y, Varela AM, Xu L, Sato Y, Liu LZ, Ding LW, Sharma A, Goh BC, Lee SC, Petersson BF, Yu FG, Macary P, Oo MZ, Ha CS, Yang H, Ogawa S, Loh KS, Koeffler HP.

Nat Genet. 2014 Aug;46(8):866-71. doi: 10.1038/ng.3006. Epub 2014 Jun 22.

PMID:
24952746
2.

Genomic and molecular characterization of esophageal squamous cell carcinoma.

Lin DC, Hao JJ, Nagata Y, Xu L, Shang L, Meng X, Sato Y, Okuno Y, Varela AM, Ding LW, Garg M, Liu LZ, Yang H, Yin D, Shi ZZ, Jiang YY, Gu WY, Gong T, Zhang Y, Xu X, Kalid O, Shacham S, Ogawa S, Wang MR, Koeffler HP.

Nat Genet. 2014 May;46(5):467-73. doi: 10.1038/ng.2935. Epub 2014 Mar 30.

3.

Tumor dormancy resulting from subcutaneous injection to SCID mice with cultured nasopharyngeal carcinoma cells is mediated via IFN-γ induction of a highly differentiated phenotype.

Chou AS, Chen HC, Li CR, Hsieh CH, Ting LL, Liao SK.

Cancer Biother Radiopharm. 2011 Aug;26(4):417-26. doi: 10.1089/cbr.2011.0958. Epub 2011 Aug 2.

PMID:
21810020
4.

Transcriptional patterns, biomarkers and pathways characterizing nasopharyngeal carcinoma of Southern China.

Fang W, Li X, Jiang Q, Liu Z, Yang H, Wang S, Xie S, Liu Q, Liu T, Huang J, Xie W, Li Z, Zhao Y, Wang E, Marincola FM, Yao K.

J Transl Med. 2008 Jun 20;6:32. doi: 10.1186/1479-5876-6-32.

5.

Whole-exome and targeted gene sequencing of gallbladder carcinoma identifies recurrent mutations in the ErbB pathway.

Li M, Zhang Z, Li X, Ye J, Wu X, Tan Z, Liu C, Shen B, Wang XA, Wu W, Zhou D, Zhang D, Wang T, Liu B, Qu K, Ding Q, Weng H, Ding Q, Mu J, Shu Y, Bao R, Cao Y, Chen P, Liu T, Jiang L, Hu Y, Dong P, Gu J, Lu W, Shi W, Lu J, Gong W, Tang Z, Zhang Y, Wang X, Chin YE, Weng X, Zhang H, Tang W, Zheng Y, He L, Wang H, Liu Y, Liu Y.

Nat Genet. 2014 Aug;46(8):872-6. doi: 10.1038/ng.3030. Epub 2014 Jul 6.

PMID:
24997986
6.

Wogonin induces cross-regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cells.

Chow SE, Chen YW, Liang CA, Huang YK, Wang JS.

J Cell Biochem. 2012 Nov;113(11):3476-85. doi: 10.1002/jcb.24224.

PMID:
22689083
7.

Comprehensive genomic characterization of cutaneous malignant melanoma cell lines derived from metastatic lesions by whole-exome sequencing and SNP array profiling.

Cifola I, Pietrelli A, Consolandi C, Severgnini M, Mangano E, Russo V, De Bellis G, Battaglia C.

PLoS One. 2013 May 21;8(5):e63597. doi: 10.1371/journal.pone.0063597. Print 2013.

8.

Overexpression of phospho-Akt correlates with phosphorylation of EGF receptor, FKHR and BAD in nasopharyngeal carcinoma.

Yip WK, Leong VC, Abdullah MA, Yusoff S, Seow HF.

Oncol Rep. 2008 Feb;19(2):319-28.

PMID:
18202777
9.

Dual phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 has a therapeutic potential and sensitizes cisplatin in nasopharyngeal carcinoma.

Yang F, Qian XJ, Qin W, Deng R, Wu XQ, Qin J, Feng GK, Zhu XF.

PLoS One. 2013;8(3):e59879. doi: 10.1371/journal.pone.0059879. Epub 2013 Mar 22.

10.

Integrated mRNA and microRNA transcriptome sequencing characterizes sequence variants and mRNA-microRNA regulatory network in nasopharyngeal carcinoma model systems.

Szeto CY, Lin CH, Choi SC, Yip TT, Ngan RK, Tsao GS, Li Lung M.

FEBS Open Bio. 2014 Jan 13;4:128-40. doi: 10.1016/j.fob.2014.01.004. eCollection 2014.

11.

Identification of a novel 12p13.3 amplicon in nasopharyngeal carcinoma.

Or YY, Chung GT, To KF, Chow C, Choy KW, Tong CY, Leung AW, Hui AB, Tsao SW, Ng HK, Yip TT, Busson P, Lo KW.

J Pathol. 2010 Jan;220(1):97-107. doi: 10.1002/path.2609.

PMID:
19718711
12.

Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line.

Wang J, Guo LP, Chen LZ, Zeng YX, Lu SH.

Cancer Res. 2007 Apr 15;67(8):3716-24.

13.

Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.

Kong WJ, Zhang S, Guo CK, Wang YJ, Chen X, Zhang SL, Zhang D, Liu Z, Kong W.

Anticancer Drugs. 2006 Mar;17(3):251-9.

PMID:
16520653
14.

A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma.

Liu Y, Cai H, Liu J, Fan H, Wang Z, Wang Q, Shao M, Sun X, Diao J, Liu Y, Shi Y, Fan Q.

Biochem Biophys Res Commun. 2013 Mar 22;432(4):660-5. doi: 10.1016/j.bbrc.2013.02.024. Epub 2013 Feb 14.

PMID:
23416081
15.
16.

Role of MIF/CXCL8/CXCR2 signaling in the growth of nasopharyngeal carcinoma tumor spheres.

Lo MC, Yip TC, Ngan KC, Cheng WW, Law CK, Chan PS, Chan KC, Wong CK, Wong RN, Lo KW, Ng WT, Lee WM, Tsao SW, Kwong LW, Lung ML, Mak NK.

Cancer Lett. 2013 Jul 10;335(1):81-92. doi: 10.1016/j.canlet.2013.01.052. Epub 2013 Feb 8.

PMID:
23403077
17.

MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.

Zhang LY, Ho-Fun Lee V, Wong AM, Kwong DL, Zhu YH, Dong SS, Kong KL, Chen J, Tsao SW, Guan XY, Fu L.

Carcinogenesis. 2013 Feb;34(2):454-63. doi: 10.1093/carcin/bgs346. Epub 2012 Nov 3.

18.

Identification of ABCG2⁺ cells in nasopharyngeal carcinoma cells.

Zhang H, Liu W, Feng X, Wang L, Jiang X, Liu D, Zhang L, Zhu B, Zhou W, Jia W, Li G, Ren C.

Oncol Rep. 2012 Apr;27(4):1177-87. doi: 10.3892/or.2011.1618. Epub 2011 Dec 30.

19.

The synergistic effect of chemical carcinogens enhances Epstein-Barr virus reactivation and tumor progression of nasopharyngeal carcinoma cells.

Fang CY, Huang SY, Wu CC, Hsu HY, Chou SP, Tsai CH, Chang Y, Takada K, Chen JY.

PLoS One. 2012;7(9):e44810. Epub 2012 Sep 14.

20.

Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma.

Tong JH, Ng DC, Chau SL, So KK, Leung PP, Lee TL, Lung RW, Chan MW, Chan AW, Lo KW, To KF.

BMC Cancer. 2010 Jun 3;10:253. doi: 10.1186/1471-2407-10-253.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk